Here are the buy-and-trade parameters for 12 Big Pharma stocks:
(ABT - Get Report) ($35.36) set a multi-year high at $38.77 on May 22. My monthly value level is $22.38 with a weekly risky level at $36.76.
(AGN - Get Report) ($85.43) set a 2013 low at $81.33 on June 24. My weekly pivot is $86.72 with a semiannual risky level at $88.65.
(AZN - Get Report) ($47.99) set a multi-year high at $53.45 on May 28, then fell to $46.87 into June 24. My annual value level is $42.53 with a quarterly risky level at $49.43.
(BMY - Get Report)
($46.30) set a multi-year high at $49.57 on June 3. My quarterly value level is $43.35 with a weekly risky level at $49.31.
(GSK - Get Report)
($50.10) set a multi-year high at $54.00 on May 28, then a low of $48.30 on June 24. My monthly value level is $47.78 with a weekly pivot at $50.57 and quarterly risky level at $51.33.
Johnson & Johnson
($86.71) set a multi-year high at $89.99 on May 22, then as low as $82.12 on June 20. My monthly value level is $85.71.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts